nodes	percent_of_prediction	percent_of_DWPC	metapath
Pindolol—hypertension—type 2 diabetes mellitus	0.424	1	CtDrD
Pindolol—ADRB3—type 2 diabetes mellitus	0.268	1	CbGaD
Pindolol—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0505	0.294	CbGbCtD
Pindolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0395	0.23	CbGbCtD
Pindolol—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0316	0.184	CbGbCtD
Pindolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0146	0.0854	CbGbCtD
Pindolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0135	0.0788	CbGbCtD
Pindolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0111	0.0647	CbGbCtD
Pindolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0106	0.062	CbGbCtD
Pindolol—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.00402	0.621	CbGeAlD
Pindolol—HTR1B—artery—type 2 diabetes mellitus	0.000769	0.119	CbGeAlD
Pindolol—Isoprenaline—PIK3R1—type 2 diabetes mellitus	0.000557	0.244	CrCbGaD
Pindolol—ADRB3—adipose tissue—type 2 diabetes mellitus	0.000542	0.0838	CbGeAlD
Pindolol—Nadolol—ADRB3—type 2 diabetes mellitus	0.000417	0.183	CrCbGaD
Pindolol—Bupranolol—ADRB3—type 2 diabetes mellitus	0.000398	0.174	CrCbGaD
Pindolol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.000305	0.133	CrCbGaD
Pindolol—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000267	0.0413	CbGeAlD
Pindolol—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000251	0.0389	CbGeAlD
Pindolol—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000222	0.0343	CbGeAlD
Pindolol—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000216	0.0333	CbGeAlD
Pindolol—Isoprenaline—ADRB3—type 2 diabetes mellitus	0.000201	0.088	CrCbGaD
Pindolol—Propranolol—ADRB3—type 2 diabetes mellitus	0.000143	0.0626	CrCbGaD
Pindolol—Betaxolol—CYP1A2—type 2 diabetes mellitus	0.000116	0.0505	CrCbGaD
Pindolol—CYP2D6—kidney—type 2 diabetes mellitus	0.000115	0.0177	CbGeAlD
Pindolol—Oedema—Orlistat—type 2 diabetes mellitus	8.58e-05	0.00098	CcSEcCtD
Pindolol—Headache—Glipizide—type 2 diabetes mellitus	8.57e-05	0.000978	CcSEcCtD
Pindolol—Tremor—Irbesartan—type 2 diabetes mellitus	8.57e-05	0.000978	CcSEcCtD
Pindolol—Palpitations—Metformin—type 2 diabetes mellitus	8.56e-05	0.000978	CcSEcCtD
Pindolol—Insomnia—Gliclazide—type 2 diabetes mellitus	8.55e-05	0.000976	CcSEcCtD
Pindolol—Shock—Valsartan—type 2 diabetes mellitus	8.54e-05	0.000976	CcSEcCtD
Pindolol—Loss of consciousness—Metformin—type 2 diabetes mellitus	8.52e-05	0.000972	CcSEcCtD
Pindolol—Nervous system disorder—Valsartan—type 2 diabetes mellitus	8.51e-05	0.000972	CcSEcCtD
Pindolol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	8.49e-05	0.000969	CcSEcCtD
Pindolol—Flatulence—Losartan—type 2 diabetes mellitus	8.48e-05	0.000968	CcSEcCtD
Pindolol—Tension—Losartan—type 2 diabetes mellitus	8.44e-05	0.000964	CcSEcCtD
Pindolol—Dizziness—Glimepiride—type 2 diabetes mellitus	8.44e-05	0.000964	CcSEcCtD
Pindolol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	8.43e-05	0.000962	CcSEcCtD
Pindolol—Nervous system disorder—Orlistat—type 2 diabetes mellitus	8.41e-05	0.000961	CcSEcCtD
Pindolol—Dizziness—Sitagliptin—type 2 diabetes mellitus	8.41e-05	0.000961	CcSEcCtD
Pindolol—Somnolence—Gliclazide—type 2 diabetes mellitus	8.4e-05	0.00096	CcSEcCtD
Pindolol—Nervousness—Losartan—type 2 diabetes mellitus	8.36e-05	0.000954	CcSEcCtD
Pindolol—Abdominal pain—Glyburide—type 2 diabetes mellitus	8.32e-05	0.00095	CcSEcCtD
Pindolol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	8.32e-05	0.00095	CcSEcCtD
Pindolol—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	8.29e-05	0.000947	CcSEcCtD
Pindolol—Muscle spasms—Losartan—type 2 diabetes mellitus	8.27e-05	0.000945	CcSEcCtD
Pindolol—Asthenia—Bromocriptine—type 2 diabetes mellitus	8.26e-05	0.000943	CcSEcCtD
Pindolol—Chest pain—Metformin—type 2 diabetes mellitus	8.25e-05	0.000942	CcSEcCtD
Pindolol—Myalgia—Metformin—type 2 diabetes mellitus	8.25e-05	0.000942	CcSEcCtD
Pindolol—Vertigo—Irbesartan—type 2 diabetes mellitus	8.21e-05	0.000938	CcSEcCtD
Pindolol—Headache—Pioglitazone—type 2 diabetes mellitus	8.21e-05	0.000937	CcSEcCtD
Pindolol—Syncope—Irbesartan—type 2 diabetes mellitus	8.2e-05	0.000936	CcSEcCtD
Pindolol—Visual impairment—Ramipril—type 2 diabetes mellitus	8.17e-05	0.000933	CcSEcCtD
Pindolol—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	8.16e-05	0.000932	CcSEcCtD
Pindolol—Fatigue—Gliclazide—type 2 diabetes mellitus	8.15e-05	0.000931	CcSEcCtD
Pindolol—Nausea—Glipizide—type 2 diabetes mellitus	8.12e-05	0.000928	CcSEcCtD
Pindolol—Vomiting—Glimepiride—type 2 diabetes mellitus	8.11e-05	0.000927	CcSEcCtD
Pindolol—Hypotension—Valsartan—type 2 diabetes mellitus	8.11e-05	0.000927	CcSEcCtD
Pindolol—Vomiting—Sitagliptin—type 2 diabetes mellitus	8.09e-05	0.000924	CcSEcCtD
Pindolol—Constipation—Gliclazide—type 2 diabetes mellitus	8.08e-05	0.000923	CcSEcCtD
Pindolol—Pain—Gliclazide—type 2 diabetes mellitus	8.08e-05	0.000923	CcSEcCtD
Pindolol—Tremor—Losartan—type 2 diabetes mellitus	8.06e-05	0.000921	CcSEcCtD
Pindolol—Rash—Glimepiride—type 2 diabetes mellitus	8.05e-05	0.000919	CcSEcCtD
Pindolol—Dermatitis—Glimepiride—type 2 diabetes mellitus	8.04e-05	0.000918	CcSEcCtD
Pindolol—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	8.04e-05	0.000918	CcSEcCtD
Pindolol—Rash—Sitagliptin—type 2 diabetes mellitus	8.02e-05	0.000916	CcSEcCtD
Pindolol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	8.01e-05	0.000915	CcSEcCtD
Pindolol—Headache—Glimepiride—type 2 diabetes mellitus	7.99e-05	0.000913	CcSEcCtD
Pindolol—Headache—Sitagliptin—type 2 diabetes mellitus	7.97e-05	0.00091	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	7.91e-05	0.000903	CcSEcCtD
Pindolol—Oedema—Metformin—type 2 diabetes mellitus	7.91e-05	0.000903	CcSEcCtD
Pindolol—Tinnitus—Ramipril—type 2 diabetes mellitus	7.9e-05	0.000902	CcSEcCtD
Pindolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	7.88e-05	0.0009	CcSEcCtD
Pindolol—Insomnia—Valsartan—type 2 diabetes mellitus	7.85e-05	0.000897	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	7.82e-05	0.000893	CcSEcCtD
Pindolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	7.8e-05	0.00089	CcSEcCtD
Pindolol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	7.79e-05	0.000889	CcSEcCtD
Pindolol—Arthralgia—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000889	CcSEcCtD
Pindolol—Myalgia—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000889	CcSEcCtD
Pindolol—Chest pain—Irbesartan—type 2 diabetes mellitus	7.78e-05	0.000889	CcSEcCtD
Pindolol—Shock—Metformin—type 2 diabetes mellitus	7.78e-05	0.000888	CcSEcCtD
Pindolol—Insomnia—Orlistat—type 2 diabetes mellitus	7.76e-05	0.000886	CcSEcCtD
Pindolol—Anxiety—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000886	CcSEcCtD
Pindolol—Nervous system disorder—Metformin—type 2 diabetes mellitus	7.75e-05	0.000886	CcSEcCtD
Pindolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	7.74e-05	0.000884	CcSEcCtD
Pindolol—Vertigo—Losartan—type 2 diabetes mellitus	7.73e-05	0.000883	CcSEcCtD
Pindolol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	7.73e-05	0.000883	CcSEcCtD
Pindolol—Somnolence—Valsartan—type 2 diabetes mellitus	7.72e-05	0.000882	CcSEcCtD
Pindolol—Syncope—Losartan—type 2 diabetes mellitus	7.72e-05	0.000881	CcSEcCtD
Pindolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	7.7e-05	0.00088	CcSEcCtD
Pindolol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	7.64e-05	0.000873	CcSEcCtD
Pindolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	7.64e-05	0.000873	CcSEcCtD
Pindolol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	7.64e-05	0.000872	CcSEcCtD
Pindolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	7.61e-05	0.000869	CcSEcCtD
Pindolol—Dry mouth—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.000869	CcSEcCtD
Pindolol—Palpitations—Losartan—type 2 diabetes mellitus	7.6e-05	0.000868	CcSEcCtD
Pindolol—Nausea—Glimepiride—type 2 diabetes mellitus	7.58e-05	0.000866	CcSEcCtD
Pindolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	7.56e-05	0.000864	CcSEcCtD
Pindolol—Nausea—Sitagliptin—type 2 diabetes mellitus	7.56e-05	0.000863	CcSEcCtD
Pindolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	7.55e-05	0.000863	CcSEcCtD
Pindolol—Asthenia—Glyburide—type 2 diabetes mellitus	7.55e-05	0.000862	CcSEcCtD
Pindolol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	7.5e-05	0.000856	CcSEcCtD
Pindolol—Fatigue—Valsartan—type 2 diabetes mellitus	7.49e-05	0.000855	CcSEcCtD
Pindolol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	7.47e-05	0.000853	CcSEcCtD
Pindolol—Oedema—Irbesartan—type 2 diabetes mellitus	7.46e-05	0.000852	CcSEcCtD
Pindolol—Pruritus—Glyburide—type 2 diabetes mellitus	7.45e-05	0.00085	CcSEcCtD
Pindolol—Mental disorder—Ramipril—type 2 diabetes mellitus	7.43e-05	0.000848	CcSEcCtD
Pindolol—Constipation—Valsartan—type 2 diabetes mellitus	7.42e-05	0.000848	CcSEcCtD
Pindolol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	7.41e-05	0.000846	CcSEcCtD
Pindolol—Fatigue—Orlistat—type 2 diabetes mellitus	7.4e-05	0.000845	CcSEcCtD
Pindolol—Hypotension—Metformin—type 2 diabetes mellitus	7.39e-05	0.000844	CcSEcCtD
Pindolol—Bisoprolol—CYP3A4—type 2 diabetes mellitus	7.39e-05	0.0323	CrCbGaD
Pindolol—Shock—Irbesartan—type 2 diabetes mellitus	7.34e-05	0.000838	CcSEcCtD
Pindolol—Pain—Orlistat—type 2 diabetes mellitus	7.34e-05	0.000838	CcSEcCtD
Pindolol—Chest pain—Losartan—type 2 diabetes mellitus	7.33e-05	0.000837	CcSEcCtD
Pindolol—Myalgia—Losartan—type 2 diabetes mellitus	7.33e-05	0.000837	CcSEcCtD
Pindolol—Arthralgia—Losartan—type 2 diabetes mellitus	7.33e-05	0.000837	CcSEcCtD
Pindolol—Vomiting—Bromocriptine—type 2 diabetes mellitus	7.32e-05	0.000836	CcSEcCtD
Pindolol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	7.32e-05	0.000836	CcSEcCtD
Pindolol—Anxiety—Losartan—type 2 diabetes mellitus	7.3e-05	0.000834	CcSEcCtD
Pindolol—Tachycardia—Irbesartan—type 2 diabetes mellitus	7.28e-05	0.000832	CcSEcCtD
Pindolol—Rash—Bromocriptine—type 2 diabetes mellitus	7.26e-05	0.000829	CcSEcCtD
Pindolol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	7.25e-05	0.000828	CcSEcCtD
Pindolol—CYP2D6—liver—type 2 diabetes mellitus	7.24e-05	0.0112	CbGeAlD
Pindolol—Tension—Ramipril—type 2 diabetes mellitus	7.24e-05	0.000827	CcSEcCtD
Pindolol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	7.21e-05	0.000824	CcSEcCtD
Pindolol—Headache—Bromocriptine—type 2 diabetes mellitus	7.21e-05	0.000824	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	7.2e-05	0.000823	CcSEcCtD
Pindolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	7.2e-05	0.000822	CcSEcCtD
Pindolol—Nervousness—Ramipril—type 2 diabetes mellitus	7.17e-05	0.000818	CcSEcCtD
Pindolol—Dry mouth—Losartan—type 2 diabetes mellitus	7.16e-05	0.000818	CcSEcCtD
Pindolol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	7.1e-05	0.000811	CcSEcCtD
Pindolol—Paraesthesia—Metformin—type 2 diabetes mellitus	7.1e-05	0.000811	CcSEcCtD
Pindolol—Muscle spasms—Ramipril—type 2 diabetes mellitus	7.09e-05	0.00081	CcSEcCtD
Pindolol—Confusional state—Losartan—type 2 diabetes mellitus	7.08e-05	0.000809	CcSEcCtD
Pindolol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	7.07e-05	0.000807	CcSEcCtD
Pindolol—Dyspnoea—Metformin—type 2 diabetes mellitus	7.05e-05	0.000805	CcSEcCtD
Pindolol—Somnolence—Metformin—type 2 diabetes mellitus	7.03e-05	0.000803	CcSEcCtD
Pindolol—Oedema—Losartan—type 2 diabetes mellitus	7.02e-05	0.000802	CcSEcCtD
Pindolol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	7.02e-05	0.000801	CcSEcCtD
Pindolol—Hypotension—Irbesartan—type 2 diabetes mellitus	6.97e-05	0.000796	CcSEcCtD
Pindolol—Dyspepsia—Metformin—type 2 diabetes mellitus	6.96e-05	0.000795	CcSEcCtD
Pindolol—Tremor—Ramipril—type 2 diabetes mellitus	6.91e-05	0.000789	CcSEcCtD
Pindolol—Shock—Losartan—type 2 diabetes mellitus	6.91e-05	0.000789	CcSEcCtD
Pindolol—Nervous system disorder—Losartan—type 2 diabetes mellitus	6.89e-05	0.000786	CcSEcCtD
Pindolol—Abdominal pain—Valsartan—type 2 diabetes mellitus	6.86e-05	0.000784	CcSEcCtD
Pindolol—Tachycardia—Losartan—type 2 diabetes mellitus	6.85e-05	0.000783	CcSEcCtD
Pindolol—Nausea—Bromocriptine—type 2 diabetes mellitus	6.84e-05	0.000781	CcSEcCtD
Pindolol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.83e-05	0.00078	CcSEcCtD
Pindolol—Fatigue—Metformin—type 2 diabetes mellitus	6.82e-05	0.000779	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6.8e-05	0.000776	CcSEcCtD
Pindolol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	6.79e-05	0.000775	CcSEcCtD
Pindolol—Abdominal pain—Orlistat—type 2 diabetes mellitus	6.78e-05	0.000775	CcSEcCtD
Pindolol—Asthenia—Gliclazide—type 2 diabetes mellitus	6.78e-05	0.000774	CcSEcCtD
Pindolol—Constipation—Metformin—type 2 diabetes mellitus	6.76e-05	0.000772	CcSEcCtD
Pindolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	6.7e-05	0.000765	CcSEcCtD
Pindolol—Vomiting—Glyburide—type 2 diabetes mellitus	6.69e-05	0.000764	CcSEcCtD
Pindolol—Pruritus—Gliclazide—type 2 diabetes mellitus	6.69e-05	0.000764	CcSEcCtD
Pindolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	6.65e-05	0.00076	CcSEcCtD
Pindolol—Rash—Glyburide—type 2 diabetes mellitus	6.64e-05	0.000758	CcSEcCtD
Pindolol—Somnolence—Irbesartan—type 2 diabetes mellitus	6.63e-05	0.000758	CcSEcCtD
Pindolol—Dermatitis—Glyburide—type 2 diabetes mellitus	6.63e-05	0.000757	CcSEcCtD
Pindolol—Vertigo—Ramipril—type 2 diabetes mellitus	6.63e-05	0.000757	CcSEcCtD
Pindolol—Syncope—Ramipril—type 2 diabetes mellitus	6.62e-05	0.000756	CcSEcCtD
Pindolol—Headache—Glyburide—type 2 diabetes mellitus	6.59e-05	0.000753	CcSEcCtD
Pindolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	6.57e-05	0.00075	CcSEcCtD
Pindolol—Hypotension—Losartan—type 2 diabetes mellitus	6.56e-05	0.000749	CcSEcCtD
Pindolol—Palpitations—Ramipril—type 2 diabetes mellitus	6.52e-05	0.000745	CcSEcCtD
Pindolol—Feeling abnormal—Metformin—type 2 diabetes mellitus	6.52e-05	0.000744	CcSEcCtD
Pindolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	6.48e-05	0.000741	CcSEcCtD
Pindolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	6.47e-05	0.000738	CcSEcCtD
Pindolol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	6.47e-05	0.000738	CcSEcCtD
Pindolol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	6.44e-05	0.000736	CcSEcCtD
Pindolol—Fatigue—Irbesartan—type 2 diabetes mellitus	6.43e-05	0.000735	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	6.4e-05	0.000731	CcSEcCtD
Pindolol—Constipation—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000729	CcSEcCtD
Pindolol—Pain—Irbesartan—type 2 diabetes mellitus	6.38e-05	0.000729	CcSEcCtD
Pindolol—Insomnia—Losartan—type 2 diabetes mellitus	6.35e-05	0.000725	CcSEcCtD
Pindolol—Paraesthesia—Losartan—type 2 diabetes mellitus	6.31e-05	0.00072	CcSEcCtD
Pindolol—Arthralgia—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000717	CcSEcCtD
Pindolol—Chest pain—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000717	CcSEcCtD
Pindolol—Myalgia—Ramipril—type 2 diabetes mellitus	6.28e-05	0.000717	CcSEcCtD
Pindolol—Dyspnoea—Losartan—type 2 diabetes mellitus	6.26e-05	0.000715	CcSEcCtD
Pindolol—Anxiety—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000715	CcSEcCtD
Pindolol—Nausea—Glyburide—type 2 diabetes mellitus	6.25e-05	0.000714	CcSEcCtD
Pindolol—Abdominal pain—Metformin—type 2 diabetes mellitus	6.25e-05	0.000714	CcSEcCtD
Pindolol—Dizziness—Gliclazide—type 2 diabetes mellitus	6.25e-05	0.000714	CcSEcCtD
Pindolol—Somnolence—Losartan—type 2 diabetes mellitus	6.24e-05	0.000713	CcSEcCtD
Pindolol—Asthenia—Valsartan—type 2 diabetes mellitus	6.23e-05	0.000711	CcSEcCtD
Pindolol—Dyspepsia—Losartan—type 2 diabetes mellitus	6.18e-05	0.000706	CcSEcCtD
Pindolol—Asthenia—Orlistat—type 2 diabetes mellitus	6.16e-05	0.000703	CcSEcCtD
Pindolol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000702	CcSEcCtD
Pindolol—Pruritus—Valsartan—type 2 diabetes mellitus	6.14e-05	0.000702	CcSEcCtD
Pindolol—Dry mouth—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000702	CcSEcCtD
Pindolol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	6.1e-05	0.000697	CcSEcCtD
Pindolol—Confusional state—Ramipril—type 2 diabetes mellitus	6.07e-05	0.000693	CcSEcCtD
Pindolol—Pruritus—Orlistat—type 2 diabetes mellitus	6.07e-05	0.000693	CcSEcCtD
Pindolol—Fatigue—Losartan—type 2 diabetes mellitus	6.05e-05	0.000691	CcSEcCtD
Pindolol—Oedema—Ramipril—type 2 diabetes mellitus	6.02e-05	0.000688	CcSEcCtD
Pindolol—Vomiting—Gliclazide—type 2 diabetes mellitus	6.01e-05	0.000686	CcSEcCtD
Pindolol—Constipation—Losartan—type 2 diabetes mellitus	6.01e-05	0.000686	CcSEcCtD
Pindolol—Pain—Losartan—type 2 diabetes mellitus	6.01e-05	0.000686	CcSEcCtD
Pindolol—Rash—Gliclazide—type 2 diabetes mellitus	5.96e-05	0.000681	CcSEcCtD
Pindolol—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.95e-05	0.00068	CcSEcCtD
Pindolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.94e-05	0.000678	CcSEcCtD
Pindolol—Shock—Ramipril—type 2 diabetes mellitus	5.92e-05	0.000677	CcSEcCtD
Pindolol—Headache—Gliclazide—type 2 diabetes mellitus	5.92e-05	0.000676	CcSEcCtD
Pindolol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	5.9e-05	0.000674	CcSEcCtD
Pindolol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	5.9e-05	0.000674	CcSEcCtD
Pindolol—Tachycardia—Ramipril—type 2 diabetes mellitus	5.88e-05	0.000671	CcSEcCtD
Pindolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.87e-05	0.00067	CcSEcCtD
Pindolol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	5.82e-05	0.000665	CcSEcCtD
Pindolol—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.79e-05	0.000661	CcSEcCtD
Pindolol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	5.74e-05	0.000656	CcSEcCtD
Pindolol—Dizziness—Valsartan—type 2 diabetes mellitus	5.74e-05	0.000656	CcSEcCtD
Pindolol—Dizziness—Orlistat—type 2 diabetes mellitus	5.67e-05	0.000648	CcSEcCtD
Pindolol—Asthenia—Metformin—type 2 diabetes mellitus	5.67e-05	0.000648	CcSEcCtD
Pindolol—Hypotension—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000643	CcSEcCtD
Pindolol—Nausea—Gliclazide—type 2 diabetes mellitus	5.61e-05	0.000641	CcSEcCtD
Pindolol—Pruritus—Metformin—type 2 diabetes mellitus	5.59e-05	0.000639	CcSEcCtD
Pindolol—Abdominal pain—Losartan—type 2 diabetes mellitus	5.55e-05	0.000634	CcSEcCtD
Pindolol—Vomiting—Valsartan—type 2 diabetes mellitus	5.52e-05	0.00063	CcSEcCtD
Pindolol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	5.49e-05	0.000627	CcSEcCtD
Pindolol—Rash—Valsartan—type 2 diabetes mellitus	5.47e-05	0.000625	CcSEcCtD
Pindolol—Dermatitis—Valsartan—type 2 diabetes mellitus	5.47e-05	0.000625	CcSEcCtD
Pindolol—Vomiting—Orlistat—type 2 diabetes mellitus	5.46e-05	0.000623	CcSEcCtD
Pindolol—Insomnia—Ramipril—type 2 diabetes mellitus	5.45e-05	0.000622	CcSEcCtD
Pindolol—Headache—Valsartan—type 2 diabetes mellitus	5.44e-05	0.000621	CcSEcCtD
Pindolol—Diarrhoea—Metformin—type 2 diabetes mellitus	5.41e-05	0.000618	CcSEcCtD
Pindolol—Rash—Orlistat—type 2 diabetes mellitus	5.41e-05	0.000618	CcSEcCtD
Pindolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000617	CcSEcCtD
Pindolol—Dermatitis—Orlistat—type 2 diabetes mellitus	5.4e-05	0.000617	CcSEcCtD
Pindolol—Headache—Orlistat—type 2 diabetes mellitus	5.37e-05	0.000614	CcSEcCtD
Pindolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000613	CcSEcCtD
Pindolol—Asthenia—Irbesartan—type 2 diabetes mellitus	5.35e-05	0.000611	CcSEcCtD
Pindolol—Somnolence—Ramipril—type 2 diabetes mellitus	5.35e-05	0.000611	CcSEcCtD
Pindolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	5.3e-05	0.000605	CcSEcCtD
Pindolol—Pruritus—Irbesartan—type 2 diabetes mellitus	5.28e-05	0.000603	CcSEcCtD
Pindolol—Dizziness—Metformin—type 2 diabetes mellitus	5.23e-05	0.000597	CcSEcCtD
Pindolol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000594	CcSEcCtD
Pindolol—Fatigue—Ramipril—type 2 diabetes mellitus	5.19e-05	0.000593	CcSEcCtD
Pindolol—Nausea—Valsartan—type 2 diabetes mellitus	5.16e-05	0.000589	CcSEcCtD
Pindolol—Constipation—Ramipril—type 2 diabetes mellitus	5.15e-05	0.000588	CcSEcCtD
Pindolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.11e-05	0.000583	CcSEcCtD
Pindolol—Nausea—Orlistat—type 2 diabetes mellitus	5.1e-05	0.000582	CcSEcCtD
Pindolol—Asthenia—Losartan—type 2 diabetes mellitus	5.04e-05	0.000575	CcSEcCtD
Pindolol—Vomiting—Metformin—type 2 diabetes mellitus	5.03e-05	0.000574	CcSEcCtD
Pindolol—Rash—Metformin—type 2 diabetes mellitus	4.99e-05	0.000569	CcSEcCtD
Pindolol—Dermatitis—Metformin—type 2 diabetes mellitus	4.98e-05	0.000569	CcSEcCtD
Pindolol—Pruritus—Losartan—type 2 diabetes mellitus	4.97e-05	0.000567	CcSEcCtD
Pindolol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000567	CcSEcCtD
Pindolol—Headache—Metformin—type 2 diabetes mellitus	4.95e-05	0.000566	CcSEcCtD
Pindolol—Dizziness—Irbesartan—type 2 diabetes mellitus	4.93e-05	0.000564	CcSEcCtD
Pindolol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000562	CcSEcCtD
Pindolol—Diarrhoea—Losartan—type 2 diabetes mellitus	4.8e-05	0.000549	CcSEcCtD
Pindolol—Abdominal pain—Ramipril—type 2 diabetes mellitus	4.76e-05	0.000544	CcSEcCtD
Pindolol—Vomiting—Irbesartan—type 2 diabetes mellitus	4.74e-05	0.000542	CcSEcCtD
Pindolol—Rash—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000537	CcSEcCtD
Pindolol—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.7e-05	0.000537	CcSEcCtD
Pindolol—Nausea—Metformin—type 2 diabetes mellitus	4.7e-05	0.000536	CcSEcCtD
Pindolol—Headache—Irbesartan—type 2 diabetes mellitus	4.67e-05	0.000534	CcSEcCtD
Pindolol—Dizziness—Losartan—type 2 diabetes mellitus	4.64e-05	0.00053	CcSEcCtD
Pindolol—Propranolol—CYP1A2—type 2 diabetes mellitus	4.5e-05	0.0197	CrCbGaD
Pindolol—Vomiting—Losartan—type 2 diabetes mellitus	4.46e-05	0.00051	CcSEcCtD
Pindolol—Nausea—Irbesartan—type 2 diabetes mellitus	4.43e-05	0.000506	CcSEcCtD
Pindolol—Rash—Losartan—type 2 diabetes mellitus	4.43e-05	0.000506	CcSEcCtD
Pindolol—Dermatitis—Losartan—type 2 diabetes mellitus	4.42e-05	0.000505	CcSEcCtD
Pindolol—Headache—Losartan—type 2 diabetes mellitus	4.4e-05	0.000502	CcSEcCtD
Pindolol—Asthenia—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000493	CcSEcCtD
Pindolol—Pruritus—Ramipril—type 2 diabetes mellitus	4.26e-05	0.000487	CcSEcCtD
Pindolol—Nausea—Losartan—type 2 diabetes mellitus	4.17e-05	0.000476	CcSEcCtD
Pindolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000471	CcSEcCtD
Pindolol—Dizziness—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000455	CcSEcCtD
Pindolol—Vomiting—Ramipril—type 2 diabetes mellitus	3.83e-05	0.000437	CcSEcCtD
Pindolol—Rash—Ramipril—type 2 diabetes mellitus	3.8e-05	0.000434	CcSEcCtD
Pindolol—Dermatitis—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000433	CcSEcCtD
Pindolol—Headache—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000431	CcSEcCtD
Pindolol—Nausea—Ramipril—type 2 diabetes mellitus	3.58e-05	0.000408	CcSEcCtD
Pindolol—Propranolol—CYP3A4—type 2 diabetes mellitus	2.98e-05	0.013	CrCbGaD
Pindolol—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	5.24e-06	0.000132	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	5.24e-06	0.000132	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—INS—type 2 diabetes mellitus	5.23e-06	0.000132	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	5.2e-06	0.000131	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	5.18e-06	0.000131	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.17e-06	0.00013	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.14e-06	0.00013	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.1e-06	0.000129	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	5.08e-06	0.000128	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	5.07e-06	0.000128	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.06e-06	0.000128	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	5.06e-06	0.000128	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.05e-06	0.000128	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.03e-06	0.000127	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	5.02e-06	0.000127	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.01e-06	0.000127	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.97e-06	0.000125	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.96e-06	0.000125	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—CCL2—type 2 diabetes mellitus	4.94e-06	0.000125	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—C3—type 2 diabetes mellitus	4.9e-06	0.000124	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT2—type 2 diabetes mellitus	4.86e-06	0.000123	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	4.85e-06	0.000123	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.8e-06	0.000121	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.8e-06	0.000121	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.76e-06	0.00012	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.7e-06	0.000119	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.7e-06	0.000119	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.7e-06	0.000119	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.67e-06	0.000118	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.67e-06	0.000118	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	4.67e-06	0.000118	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.66e-06	0.000118	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.66e-06	0.000118	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AGT—type 2 diabetes mellitus	4.65e-06	0.000118	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.65e-06	0.000118	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.61e-06	0.000116	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.59e-06	0.000116	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.59e-06	0.000116	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.59e-06	0.000116	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.58e-06	0.000116	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.58e-06	0.000116	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.58e-06	0.000116	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.57e-06	0.000115	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—APOE—type 2 diabetes mellitus	4.56e-06	0.000115	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—LEP—type 2 diabetes mellitus	4.56e-06	0.000115	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.55e-06	0.000115	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.55e-06	0.000115	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.54e-06	0.000115	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.52e-06	0.000114	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.51e-06	0.000114	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.51e-06	0.000114	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AVP—type 2 diabetes mellitus	4.49e-06	0.000113	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.49e-06	0.000113	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.47e-06	0.000113	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.47e-06	0.000113	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.45e-06	0.000112	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.44e-06	0.000112	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.42e-06	0.000112	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.41e-06	0.000111	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.37e-06	0.00011	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	4.36e-06	0.00011	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APOB—type 2 diabetes mellitus	4.34e-06	0.00011	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	4.33e-06	0.000109	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.32e-06	0.000109	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—RELA—type 2 diabetes mellitus	4.32e-06	0.000109	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.3e-06	0.000109	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.27e-06	0.000108	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	4.27e-06	0.000108	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	4.27e-06	0.000108	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.24e-06	0.000107	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	4.24e-06	0.000107	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	4.19e-06	0.000106	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	4.16e-06	0.000105	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	4.16e-06	0.000105	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	4.16e-06	0.000105	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.15e-06	0.000105	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—LPL—type 2 diabetes mellitus	4.14e-06	0.000105	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	4.13e-06	0.000104	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.07e-06	0.000103	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.07e-06	0.000103	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	4.06e-06	0.000103	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	4.06e-06	0.000102	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	4.01e-06	0.000101	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.99e-06	0.000101	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.98e-06	0.0001	CbGpPWpGaD
Pindolol—ADRB3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.93e-06	9.92e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.91e-06	9.86e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	3.9e-06	9.85e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—INS—type 2 diabetes mellitus	3.9e-06	9.84e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.89e-06	9.83e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.89e-06	9.82e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.87e-06	9.76e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.83e-06	9.68e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.82e-06	9.64e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	3.82e-06	9.64e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.77e-06	9.51e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.77e-06	9.51e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.75e-06	9.47e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—C3—type 2 diabetes mellitus	3.73e-06	9.42e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	3.73e-06	9.42e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	3.73e-06	9.42e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	3.73e-06	9.42e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.72e-06	9.39e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.71e-06	9.37e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.71e-06	9.36e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.68e-06	9.29e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	3.66e-06	9.25e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.64e-06	9.2e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.64e-06	9.19e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.64e-06	9.19e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.63e-06	9.17e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.63e-06	9.17e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.63e-06	9.17e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	3.63e-06	9.16e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.63e-06	9.16e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.59e-06	9.07e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.58e-06	9.04e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.57e-06	9.01e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.57e-06	9e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.56e-06	8.99e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.55e-06	8.97e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.55e-06	8.97e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.55e-06	8.97e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.55e-06	8.96e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.55e-06	8.95e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.51e-06	8.87e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.49e-06	8.8e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	3.47e-06	8.77e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	3.47e-06	8.77e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.43e-06	8.67e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.43e-06	8.65e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.42e-06	8.63e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.42e-06	8.63e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.41e-06	8.62e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.39e-06	8.56e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.37e-06	8.52e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.37e-06	8.52e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.35e-06	8.46e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.3e-06	8.34e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.29e-06	8.31e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.28e-06	8.27e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.24e-06	8.18e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.23e-06	8.17e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.23e-06	8.17e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	3.22e-06	8.12e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.17e-06	8e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	3.1e-06	7.83e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.1e-06	7.83e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.05e-06	7.71e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	3.04e-06	7.66e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.03e-06	7.65e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3e-06	7.58e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3e-06	7.57e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.99e-06	7.54e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.99e-06	7.54e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.97e-06	7.5e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	2.97e-06	7.49e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.94e-06	7.41e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.93e-06	7.41e-05	CbGpPWpGaD
Pindolol—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.93e-06	7.39e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.92e-06	7.38e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.92e-06	7.37e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.9e-06	7.32e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.88e-06	7.28e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.87e-06	7.25e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.87e-06	7.24e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.86e-06	7.21e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.85e-06	7.2e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.79e-06	7.04e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.79e-06	7.04e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.79e-06	7.04e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.78e-06	7.01e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.74e-06	6.92e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.74e-06	6.91e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.73e-06	6.88e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.72e-06	6.87e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.72e-06	6.87e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.71e-06	6.85e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.66e-06	6.72e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.66e-06	6.72e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.66e-06	6.71e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.66e-06	6.71e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.6e-06	6.57e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.6e-06	6.57e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.59e-06	6.53e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.56e-06	6.47e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.54e-06	6.41e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.53e-06	6.38e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.51e-06	6.33e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.49e-06	6.27e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.48e-06	6.25e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.46e-06	6.21e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.45e-06	6.19e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.41e-06	6.09e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.38e-06	6.01e-05	CbGpPWpGaD
Pindolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.33e-06	5.89e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.31e-06	5.83e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.3e-06	5.79e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.29e-06	5.77e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.28e-06	5.77e-05	CbGpPWpGaD
Pindolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.28e-06	5.76e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.26e-06	5.71e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.26e-06	5.7e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.25e-06	5.67e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.24e-06	5.66e-05	CbGpPWpGaD
Pindolol—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.23e-06	5.63e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.22e-06	5.59e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.21e-06	5.58e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.2e-06	5.54e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.18e-06	5.51e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.17e-06	5.48e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.16e-06	5.45e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.14e-06	5.39e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.14e-06	5.39e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.13e-06	5.37e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.12e-06	5.35e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.11e-06	5.33e-05	CbGpPWpGaD
Pindolol—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.11e-06	5.32e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.1e-06	5.31e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.09e-06	5.27e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.07e-06	5.23e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.07e-06	5.22e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.03e-06	5.11e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.01e-06	5.08e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.97e-06	4.97e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.96e-06	4.95e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.93e-06	4.86e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.92e-06	4.84e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.88e-06	4.73e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.85e-06	4.68e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.82e-06	4.59e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.8e-06	4.54e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.76e-06	4.45e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.76e-06	4.44e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.73e-06	4.36e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.72e-06	4.35e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.7e-06	4.3e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.69e-06	4.26e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.67e-06	4.21e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.59e-06	4.03e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.59e-06	4.03e-05	CbGpPWpGaD
Pindolol—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.57e-06	3.97e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.46e-06	3.68e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.36e-06	3.42e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.33e-06	3.35e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.3e-06	3.27e-05	CbGpPWpGaD
Pindolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.25e-06	3.16e-05	CbGpPWpGaD
Pindolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.22e-06	3.09e-05	CbGpPWpGaD
Pindolol—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.2e-06	3.02e-05	CbGpPWpGaD
Pindolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	7.33e-07	1.85e-05	CbGpPWpGaD
